Products & Services » Diagnostics » Serum Infliximab/HACA

PROMETHEUS® Serum Infliximab/HACA Measurement
Infliximab concentrations may vary among equally dosed patients. PROMETHEUS® Serum Infliximab/HACA Measurement can aid physicians in determining the dose of infliximab and guide infusion intervals. The HACA portion of the test detects Human Anti-Chimeric Antibodies (antibodies against infliximab). Patients that develop HACA may experience infusion reactions and/or a reduced duration of efficacy of infliximab.

For references see product information brochure.

Resources

Serum Infliximab/HACA data sheet

Infliximab (HACA) Product Detail

Sample insurance correspondence for
PROMETHEUS® Serum Infliximab/HACA Measurement

Patient Coverage Request

Letter of Appeal

Letter of Medical Necessity

Prometheus diagnostic services provide important information to aid in the diagnosis and management of certain diseases and conditions. How this information is used to guide patient care is the responsibility of the physician.

Reference within this site to any specific advertisement or promotion of a non-Prometheus product
does not constitute an endorsement or recommendation by Prometheus.
© 2010 Prometheus. All Rights Reserved. Mkt Doc 100 Rev. F